Management of adult patients with alcoholic liver disease: clinical guidelines of the Russian Scientific Liver Society

Management of adult patients with alcoholic liver disease: clinical guidelines of the Russian Scientific Liver Society

The aim of publication. To present clinical guidelines of the Russian Scientific Liver Society on diagnosis and treatment of alcoholic liver disease to general practitioners. Summary. Harmful alcohol intake is the burning issue for Russia. The alcoholic liver disease (ALD) is a clinical and morpholo...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Ivashkin, M. V. Mayevskaya, Ch. S. Pavlov, Yu. P. Sivolap, V. D. Lunkov, M. S. Zharkova, R. V. Maslennikov
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	алкогольная болезнь печени опросник cage опросник audit индекс мэддрея тиамин адеметионин эссенциальные фосфолипиды
Online Access:	https://www.gastro-j.ru/jour/article/view/190
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment compliance of liver cirrhosis patients
by: Ye. R. Olevskaya, et al.
Published: (2018-08-01)

Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12)
by: I. G. Bakulin, et al.
Published: (2018-08-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01)

The impact of bacterial overgrowth syndrome and systemic inflammation on abdominal hemodynamics in liver cirrhosis
by: R. V. Maslennikov, et al.
Published: (2018-08-01)

Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China
by: M. Ch. Semenistaya, et al.
Published: (2018-08-01)

Options of dyslipidemia treatment at non-alcoholic fatty liver disease
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Возможности применения Опросника «7х7» (7 симптомов за 7 дней) для оценки динамики симптомов функциональной диспепсии и синдрома раздраженного кишечника
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Metabolism of bile acids, liver diseases and microbiome
by: Yu. V. Yevsyutina, et al.
Published: (2018-08-01)

The effect of Clostridium difficile infection on the course of liver cirrhosis
by: A. A. Driga, et al.
Published: (2018-08-01)

Small intestinal bacterial overgrowth syndrome and systemic inflammation in pathogenesis of hemodynamic changes at liver cirrhosis
by: R. V. Maslennikov, et al.
Published: (2018-08-01)

The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B
by: Chavdar S. Pavlov, et al.
Published: (2016-08-01)

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Шкала ценностного отношения к детям: разработка, валидизация, стандартизация
by: Константин Викторович Карпинский
Published: (2024-12-01)

Infusion therapy for chronic liver diseases
by: I. A. Kurkina, et al.
Published: (2018-08-01)

Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
by: P. D. Bessonov, et al.
Published: (2018-08-01)

Principles of diuretic therapy at liver cirrhosis
by: A. I. Dyadyk, et al.
Published: (2018-08-01)

Liver cirrhosis epidemiology in Chelyabinsk region in 2006-2015
by: A. I. Dolgushina, et al.
Published: (2018-08-01)

Primary liver lymphoma: review of the literature and clinical case presentation
by: A. K. Smolyaninova, et al.
Published: (2018-08-01)

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Влияние курсового приема L-орнитин- L-аспартата на фиброз и стеатоз печени у больных ассоциированной с нарушениями метаболизма жировой болезнью печени (неалкогольной жировой болезнью печени), имеющих гипераммониемию
by: Е. V. Garanina
Published: (2021-12-01)

Modern concept of bacterial complications at liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2010-12-01)

Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Complications
by: V. T. Ivashkin, et al.
Published: (2022-03-01)

The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01)

Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers
by: A. F. Sheptulina, et al.
Published: (2016-08-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Recent trends in studying of alcohol-induced liver disease
by: I. I. Komkova, et al.
Published: (2011-12-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

Laparoscopic and open surgery with D3-lymphadenectomy in patients with left-sided colon cancer: clinical and pathological parallels
by: P. V. Tsarkov, et al.
Published: (2018-08-01)

Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
by: M. V. Mayevskaya, et al.
Published: (2019-09-01)

Structure and Functions of Human Serum Albumin in Normal Conditions and in Patients with Liver Cirrhosis
by: A. A. Turkina, et al.
Published: (2022-12-01)

Clinical guidelines of the Russian gastroenterological association and the Russian society on study of the liver on diagnostics and treatment of cholestasis
by: V. T. Ivashkin, et al.
Published: (2015-05-01)

Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
by: Yu. V. Yevsyutina
Published: (2018-08-01)

Clinical round: 27 year old patient with initially diagnosed Crohn's disease and severe protein and energy deficiency
by: V. S. Scherbakha, et al.
Published: (2018-08-01)

Vascular malformations of the lungs and the liver at patient with hereditary hemorrhagic teleangiectasia
by: M. S. Zharkova, et al.
Published: (2011-03-01)

Hypercoagulation syndrome at liver cirrhosis
by: I. A. Kurkina, et al.
Published: (2014-12-01)

Hemorrhagic syndrome at liver cirrhosis
by: I. A. Kurkina, et al.
Published: (2012-11-01)